Bajaj HealthCare Intrinsic Value
BAJAJHCARE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹347.60 | ₹278.08 - ₹417.12 | +24.9% | EPS: ₹15.80, Sector P/E: 22x |
| Book Value Method | asset | ₹582.50 | ₹524.25 - ₹640.75 | +109.4% | Book Value/Share: ₹291.25, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹556.40 | ₹500.76 - ₹612.04 | +100.0% | Revenue/Share: ₹393.75, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹556.40 | ₹500.76 - ₹612.04 | +100.0% | EBITDA: ₹109.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹127.65 | ₹102.12 - ₹153.18 | -54.1% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹101.12 | ₹91.01 - ₹111.23 | -63.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹234.72 | ₹211.25 - ₹258.19 | -15.6% | Revenue Growth: -1.9%, Adj P/E: 14.9x |
| ROE Based Valuation | profitability | ₹375.00 | ₹337.50 - ₹412.50 | +34.8% | ROE: 10.7%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹321.78 | ₹289.60 - ₹353.96 | +15.7% | EPS: ₹15.80, BVPS: ₹291.25 |
Want to compare with current market value? Check BAJAJHCARE share price latest .
Valuation Comparison Chart
BAJAJHCARE Intrinsic Value Analysis
What is the intrinsic value of BAJAJHCARE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Bajaj HealthCare (BAJAJHCARE) is ₹347.60 (median value). With the current market price of ₹278.20, this represents a +24.9% variance from our estimated fair value.
The valuation range spans from ₹101.12 to ₹582.50, indicating ₹101.12 - ₹582.50.
Is BAJAJHCARE undervalued or overvalued?
Based on our multi-method analysis, Bajaj HealthCare (BAJAJHCARE) appears to be trading below calculated value by approximately 24.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.11 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.7% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 15.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.76x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Bajaj HealthCare
Additional stock information and data for BAJAJHCARE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹22 Cr | ₹15 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹92 Cr | ₹87 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-22 Cr | ₹-69 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-37 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹44 Cr | ₹-11 Cr | Positive Operating Cash Flow | 6/10 |